Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Κατάταξη σε μετοχές #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Τιμή μετοχής
$150.78
Τελευταίος συγχρονισμός: 2026-09-18
Κεφαλαιοποίηση
$187.20B
Αλλαγή (1 ημέρα)
-0.08%
Αλλαγή (1 έτος)
32.15%
Χώρα
US
Εμπόριο Gilead Sciences, Inc. (GILD)

Κατηγορία

Δείκτης P/B για Gilead Sciences, Inc. (GILD)
Δείκτης P/B στις September 2026 TTM: 15.39
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Gilead Sciences, Inc., ο τρέχων δείκτης P/B (TTM) είναι 15.39. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 5.96.
Ιστορικό P/B για την Gilead Sciences, Inc. από 2000 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
Έτος Δείκτης P/B Αλλαγή
2026 (TTM) 15.39 -100.00%
2025 0.00 -100.00%
2024 5.96 34.58%
2023 4.43 -12.71%
2022 5.07 17.19%
2021 4.33 7.59%
2020 4.02 9.82%
2019 3.66 -3.49%
2018 3.80 -17.12%
2017 4.58 -9.78%
2016 5.08 -36.48%
2015 7.99 -14.05%
2014 9.30 -7.89%
2013 10.10 68.83%
2012 5.98 27.09%
2011 4.71 -11.06%
2010 5.29 -13.96%
2009 6.15 -44.20%
2008 11.02 -10.79%
2007 12.35 -24.75%
2006 16.42 108.13%
2005 7.89 -2.41%
2004 8.08 -30.89%
2003 11.69 0.49%
2002 11.64 -15.83%
2001 13.83 28.66%
2000 10.75 0.00%
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Δείκτης P/B Διαφορά Δείκτη P/B Χώρα
29.9692 94.78%
US
7.6479 -50.29%
US
-78.0908 -607.54%
US
8.4776 -44.90%
CH
8.5385 -44.51%
US